However, there were contrast results that treatment with tubastatin A did not rescue impairments in spontaneous movements or sensorimotor reflexes in an MPP+-induced Zebrafish model of PD, while treatment with 4-phenylbutyrate, a pan-HDAC inhibitor, improved those PD symptoms [72]. Here, HDAC9 is linked to Parkinson disease.